Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation - PubMed (original) (raw)

Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation

S V Paushkin et al. Mol Cell Biol. 1997 May.

Abstract

The SUP45 and SUP35 genes of Saccharomyces cerevisiae encode polypeptide chain release factors eRF1 and eRF3, respectively. It has been suggested that the Sup35 protein (Sup35p) is subject to a heritable conformational switch, similar to mammalian prions, thus giving rise to the non-Mendelian [PSI+] nonsense suppressor determinant. In a [PSI+] state, Sup35p forms high-molecular-weight aggregates which may inhibit Sup35p activity, leading to the [PSI+] phenotype. Sup35p is composed of the N-terminal domain (N) required for [PSI+] maintenance, the presumably nonfunctional middle region (M), and the C-terminal domain (C) essential for translation termination. In this study, we observed that the N domain, alone or as a part of larger fragments, can form aggregates in [PSI+] cells. Two sites for Sup45p binding were found within Sup35p: one is formed by the N and M domains, and the other is located within the C domain. Similarly to Sup35p, in [PSI+] cells Sup45p was found in aggregates. The aggregation of Sup45p is caused by its binding to Sup35p and was not observed when the aggregated Sup35p fragments did not contain sites for Sup45p binding. The incorporation of Sup45p into the aggregates should inhibit its activity. The N domain of Sup35p, responsible for its aggregation in [PSI+] cells, may thus act as a repressor of another polypeptide chain release factor, Sup45p. This phenomenon represents a novel mechanism of regulation of gene expression at the posttranslational level.

PubMed Disclaimer

Cited by

Mutations in the highly conserved GGQ motif of class 1 polypeptide release factors abolish ability of human eRF1 to trigger peptidyl-tRNA hydrolysis.
Frolova LY, Tsivkovskii RY, Sivolobova GF, Oparina NY, Serpinsky OI, Blinov VM, Tatkov SI, Kisselev LL. Frolova LY, et al. RNA. 1999 Aug;5(8):1014-20. doi: 10.1017/s135583829999043x. RNA. 1999. PMID: 10445876 Free PMC article.
Translation termination in eukaryotes: polypeptide release factor eRF1 is composed of functionally and structurally distinct domains.
Frolova LY, Merkulova TI, Kisselev LL. Frolova LY, et al. RNA. 2000 Mar;6(3):381-90. doi: 10.1017/s135583820099143x. RNA. 2000. PMID: 10744022 Free PMC article.
Yeast J-protein Sis1 prevents prion toxicity by moderating depletion of prion protein.
Kumar J, Reidy M, Masison DC. Kumar J, et al. Genetics. 2021 Oct 2;219(2):iyab129. doi: 10.1093/genetics/iyab129. Genetics. 2021. PMID: 34849884 Free PMC article.
Molecular basis for transmission barrier and interference between closely related prion proteins in yeast.
Afanasieva EG, Kushnirov VV, Tuite MF, Ter-Avanesyan MD. Afanasieva EG, et al. J Biol Chem. 2011 May 6;286(18):15773-80. doi: 10.1074/jbc.M110.183889. Epub 2011 Mar 15. J Biol Chem. 2011. PMID: 21454674 Free PMC article.
Amyloid-associated activity contributes to the severity and toxicity of a prion phenotype.
Pezza JA, Villali J, Sindi SS, Serio TR. Pezza JA, et al. Nat Commun. 2014 Jul 15;5:4384. doi: 10.1038/ncomms5384. Nat Commun. 2014. PMID: 25023996 Free PMC article.

References

1. Genetics. 1991 Jul;128(3):513-20 - PubMed
1. Biochemistry. 1993 Mar 2;32(8):1991-2002 - PubMed
1. Curr Genet. 1993 Sep;24(3):268-70 - PubMed
1. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):10962-6 - PubMed
1. Science. 1994 Apr 22;264(5158):566-9 - PubMed

Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation - PubMed (original) (raw)